A phase 2 feasibility study of sequential, dose intensive chemotherapy to treat progressive low-grade gliomas in children.

Background: Low-grade gliomas (LGGs) comprise nearly 35% of pediatric brain tumors and often occur in young children. Many cannot be resected and radiation therapy can be associated with excessive toxicity in children. Centrally located tumors in young children, and those that progress after radiation remain therapeutic challenges.